Subtle Medical

Info

Description

SubtlePET’s artificial intelligence (AI)-powered technology enables hospitals and imaging centers to enhance images from faster PET scans. The software aims to decrease PET exam durations by up to 4-fold, increasing the total number of patients that can be scanned daily. Faster scans lead to an improved patient experience during imaging procedures while boosting hospital throughput and profitability.

SubtlePET enables hospitals and imaging centers to scan more patients in a day compared to conventional PET imaging without the need for capital expenditures. It helps hospitals and imaging centers enhance their bottom line in today’s competitive healthcare environment. The technology utilizes deep learning algorithms that integrate seamlessly with any PET scanner (both PET/CT and PET/MR) and PACS system to enhance images during acquisition without any interruption or alteration in the radiologist’s workflow. SubtlePET reduces patient time in the scanner, which is particularly beneficial for the elderly, children, and those undergoing repeat PET exams.

SubtlePET received FDA Clearance and CE Mark approval in November, 2018. It is the first AI software FDA cleared for imaging enhancement. It is currently in pilot clinical use in multiple university hospitals and imaging centers in the U.S. and abroad.

Company News

Subtle Medical Receives Health Canada Approval for Increased Imaging Efficiency

/
DateOct 13, 2021
Subtle Medical, a healthcare technology company improving the quality and efficiency of medical imaging, announced today Health Canada/Santé Canada approval for their suite of AI-powered image enhancement solutions.
Read More →

Subtle Medical Receives Health Canada Approval for Increased Imaging Efficiency

/
DateOct 13, 2021
Subtle Medical, a healthcare technology company improving the quality and efficiency of medical imaging, announced today Health Canada/Santé Canada approval for their suite of AI-powered image enhancement solutions.
Read More →

Subtle Medical Raises $12.2 Million in Series A Funding to Expand Its AI Imaging Solutions

/
DateNov 19, 2020
Subtle will use the funds to grow their product portfolio and support the global demand to make medical imaging faster and safer for all.
Read More →

Subtle Medical Named to the 2020 CB Insights AI 100 List of Most Innovative Artificial Intelligence Startups

/
DateMar 3, 2020
"The acceptance into the CB Insights AI Top 100 list marks a tremendous milestone for Subtle Medical," said Enhao Gong, PhD, Founder/CEO of Subtle Medical. "We have graduated from a promising start-up to a commercial company deploying software products that directly add value for patients and the centers that serve them. Through our deep learning-powered software solutions for accelerated image acquisition, hospitals and imaging centers can reap impressive efficiency gains while improving patient satisfaction. We are honored to be mentioned among this elite class of companies using AI to improve healthcare."
Read More →